StonvexLoading…
StonvexStonvexStonvexCore line items from STX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-03 | Q1 2026 2026-01-02 | Q4 2025 2025-10-03 | Annual 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $8.57B | $5.45B | $2.63B | $9.10B |
Operating Income | $2.54B | $1.54B | $694.00M | $1.89B |
Net Income | $1.89B | $1.14B | $549.00M | $1.47B |
EPS (Diluted) | $8.29 | $5.03 | $2.43 | $6.77 |
Total Assets | $8.89B | $8.71B | $8.44B | $8.02B |
Total Liabilities | $7.80B | $8.25B | $8.51B | $8.48B |
Cash & Equivalents | $1.15B | $1.05B | $1.11B | $891.00M |
Free Cash Flow OCF − CapEx | $1.99B | $1.03B | $427.00M | $818.00M |
Shares Outstanding | 224.41M | 218.11M | 213.53M | 212.67M |